Bristol-Myers Squibb Company
Patents, Design & Utilities
Last updated:
List of all Bristol-Myers Squibb Company patents 772 in total
| Status | Patent |
|---|---|
Application | Utility: SERUM ALBUMIN-BINDING FIBRONECTIN TYPE III DOMAINS Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Grant | Utility: Multicyclic compounds as farnesoid X receptor modulators Filling date: 6 Sep 2025 Issue date: 28 Jun 2022 |
Application | Utility: ANTI-NKG2A ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 23 Jun 2022 |
Grant | Utility: Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof Filling date: 6 Sep 2025 Issue date: 21 Jun 2022 |
Application | Utility: Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Treat Tumors Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: ANTIBODY HEAVY CHAIN CONSTANT DOMAINS Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Antisense oligonucleotides targeting alpha-synuclein and uses thereof Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Immunomodulators Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Interleukin-2/Interleukin-2 receptor alpha fusion proteins and methods of use Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Grant | Utility: Supramolecular high affinity protein-binding system for purification of biomacromolecules Filling date: 6 Sep 2025 Issue date: 14 Jun 2022 |
Application | Utility: PROCESS FOR THE PREPARATION OF N-((1R,2S,5R)-5-(TERT-BUTYLAMINO)-2-((S)-3-(7-TERT-BUTYLPYRAZOLO[1,5-A][1- ,3,5]TRIAZIN-4-YLAMINO)-2-OXOPYRROLIDIN-1-YL)CYCLOHEXYL)ACETAMIDE Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Grant | Utility: Cyclohexyl acid pyrazole azoles as LPA antagonists Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Compositions and methods of treating cancer Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Antibodies against CD73 and uses thereof Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 7 Jun 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Application | Utility: AMORPHOUS AND CRYSTALLINE FORMS OF IDO INHIBITORS Filling date: 6 Sep 2025 Issue date: 2 Jun 2022 |
Grant | Utility: Optimization of antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereof Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: High pH protein refolding methods Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Grant | Utility: PET imaging with PD-L1 binding polypeptides Filling date: 6 Sep 2025 Issue date: 31 May 2022 |
Application | Utility: USE OF LOW PH AND DEXTRAN SULFATE DURING HARVEST TREATMENT FOR PROTEIN PURIFICATION Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: COMPOSITIONS AND METHODS OF TREATING CANCER Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: ADDITIVE SYSTEMS FOR USE IN PROTEIN PEGYLATION Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Grant | Utility: Cyclic dinucleotides as anticancer agents Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Grant | Utility: Inhibitors of indoleamine 2,3-dioxygenase and methods of their use Filling date: 6 Sep 2025 Issue date: 24 May 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 19 May 2022 |
Application | Utility: CYTOKINE PROFILING ANALYSIS Filling date: 6 Sep 2025 Issue date: 19 May 2022 |
Grant | Utility: Synthetic process Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Grant | Utility: Methods of treating colorectal cancer Filling date: 6 Sep 2025 Issue date: 17 May 2022 |
Application | Utility: METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS USING A DOMAIN ANTIBODY DIRECTED AGAINST CD28 Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: TREATMENT OF LUNG CANCER USING AN ANTI-FUCOSYL-GM1 ANTIBODY Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: ANTAGONISTIC CD40 MONOCLONAL ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: NOVEL SYNTHETIC OPTIONS TOWARDS THE MANUFACTURE OF (6R,10S)-10-{4-[5-CHLORO-2-(4-CHLORO-1H-1,2,3-TRIAZOL-1-YL)PHENYL]-6-OXO-- 1(6H)-PYRIMIDINYL}- 1-(DIFLUOROMETHYL)-6-METHYL-1,4,7,8,9,10-HEXAHYDRO-11,15-(METHENO)PYRAZOL- O[4,3-B][1,7]DIAZACYCLOTETRADECIN-5(6H)-ONE Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: ENHANCED PERFORMANCE OF AMORPHOUS SOLID AND SOLUBILIZED FORMULATIONS FOR ACHIEVING THERAPEUTIC PLASMA CONCENTRATIONS Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: SMALL MOLECULE INHIBITORS OF GALECTIN-3 Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: SUBSTITUTED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: TREATMENT OF PD-L1-NEGATIVE MELANOMA USING AN ANTI-PD-1 ANTIBODY AND AN ANTI-CTLA-4 ANTIBODY Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Grant | Utility: Cyclohexyl acid triazole azoles as LPA antagonists Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Grant | Utility: Cyclohexyl acid isoxazole azines as LPA antagonists Filling date: 6 Sep 2025 Issue date: 3 May 2022 |
Application | Utility: USE OF ANTI-CTLA-4 ANTIBODIES WITH ENHANCED ADCC TO ENHANCE IMMUNE RESPONSE TO A VACCINE Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Application | Utility: SUBSTITUTED QUINOLINYLCYCLOHEXYLPROPANAMIDE COMPOUNDS AND IMPROVED METHODS FOR THEIR PREPARATION Filling date: 6 Sep 2025 Issue date: 28 Apr 2022 |
Grant | Utility: Cyclohexyl acid pyrazole azines as LPA antagonists Filling date: 6 Sep 2025 Issue date: 26 Apr 2022 |
Application | Utility: TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: FIBRONECTIN BASED SCAFFOLD PROTEINS HAVING IMPROVED STABILITY Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Grant | Utility: Amino indole compounds useful as TLR inhibitors Filling date: 6 Sep 2025 Issue date: 19 Apr 2022 |
Showing 50 to 100 of 772 patents.